MAXTOF - 5

MAXTOF 5 DISCRIPTION: TOFACITINIB IS USEFUL OPTION FOR THE TREATMENT OF PATIENTS WITH RA. EFFECTIVE TREATMENT  OF CHRONIC PLAQUE PSORIASIS. TOFACITINIB  DEMONSTRATED CONSISTENT SAFETY AND PERSISTENT EFFICACY OVER 48 MONTHS IN PATINET WITH RA. WORKS BY BLOCKING THE BODY ‘S PRODUCATION OF ENZYMES CALLED JANUS KINASES (JAK’s) JAK’s PLAY A ROLE IN JOINT INFLAMMTION  IN RA, WHICH CAN CAUSE PAIN, SWELLING AND STIFFNESS. APPROVED FOR ADULTS WITH  MODEREATE  TO SEVERE ULCERATIVE COLITIS  IN WHOM TUMOR  NECROSIS FACTOR BLOCKERS DID NOT WORK WELL OR CANNOT BE TOLERATED. INDICATION:RHEUMATOID ARTHRITIS  PSORIATIC  ARTHRITIS  ULCERATIVE COLITIS  VITILIGO ANKYLOSING SPONDYLITIS